- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Researchers Kuznetsowv and Kuznetsov developed a useful mathematical model to describe the propagation of a prion concentration pulse entering a tunneling nanotube from an infected immune cell and propagating toward a neuron cell.This discovery is hoped to be utilized by dedicated prion researchers and to further advance therapeutic strategies for the affected patients.
A recently published article in Nanotube Therapy(2012), open access journal by Versita, addresses a current neuroengineering and pathology research problem concerning prion infection and transport within neuronal cells. The article by Kuznetsov and Kuznetsov features a newly developed, ground-breaking computational model of prion transport from an infected immune cell to a neural cell. The development advances our understanding of prion diseases - which are usually rapidly progressive and always fatal - with Creutzfeldt Jacobs Disease (CJD) to name the most infamous one. The model is the first computational prototype of prion transport through tunneling nanotubes of infected cells.
The symptoms of CJD are caused by the progressive death of the brain's nerve cells, which is related to the build-up of abnormal prion proteins forming amyloids. When brain tissue from a CJD patient is examined under a microscope, many tiny holes can be seen where whole areas of nerve cells have died.
Underlining the research findings, Professor David Foster of the University of Rochester said:
In their paper "A minimal model of prion transport through a tunneling nanotube," Nanotube Therapy (2012)", the authors developed a useful mathematical model to describe the propagation of a prion concentration pulse entering a tunneling nanotube from an infected immune cell and propagating toward a neuron cell. The model accounts for both lateral diffusion and driven transport in endosomes. The results are useful since they predict that actomyosin dependent transport is the major mechanism of prion transfer in tunneling nanotubes. Since tunneling nanotubes play an important role in many diseases, this model serves as an important step toward a better understanding of prion transport.
The researchers, working in collaboration, formulated and solved a mathematical model that represents the basic system of a prion molecule in a membrane nanotube. The model predicts that actomyosin-dependent transport, rather than lateral diffusion, is the major mechanism of prion transfer through tunneling nanotubes. This discovery is hoped to be utilized by dedicated prion researchers and to further advance therapeutic strategies for the affected patients.
Versita www.versita.com is one of the world's leading publishers of open access scientific content. Today Versita publishes about 350 own and third-party scholarly journals across all major disciplines. The company was established in 2001 and is now part of the De Gruyter publishing group www.degruyter.com. Since 2006 Versita has been a member of Association of Learned and Professional Society Publishers and International Association of Scientific, Technical & Medical Publishers. Versita's book and journal programs have been endorsed by the international research community and some of the world's top scientists - Nobel Prize Winners included. The company is on the constant mission to make best scientific content freely available to all scholars and readers alike.
For more information, please click here
Phone: +48 660476421
Copyright © Versita LtdIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Two UCSB Professors Receive Early Career Research Awards: The Department of Energy’s award for young scientists acknowledges UC Santa Barbara’s standing as a top tier research institution May 29th, 2015
New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
New technique speeds nanoMRI imaging: Multiplexing technique for nanoscale magnetic resonance imaging developed by researchers in Switzerland cuts normal scan time from two weeks to two days May 28th, 2015
QuantumSphere Announces Production-Scale Validation of Nano Iron Catalysts for Multi-Billion Dollar Ammonia Industry: Significant Improvement in Ammonia Production for Agricultural Fertilizer, Global Food Crops May 7th, 2015